New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
07:08 EDTAKRXAkorn price target raised to $33 from $30 at Piper Jaffray
Piper Jaffray raised its price target for Akorn shares to $33 to reflect the company's acquisition of VersaPharm. Piper believes Akorn has one of the most attractive long-term growth profiles in the broader specialty pharma space and it keeps an Overweight rating on the stock.
News For AKRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
07:45 EDTAKRXAkorn looks positive into Q3 results, says RBC Capital
Subscribe for More Information
October 14, 2014
06:33 EDTAKRXAkorn initiated with a Buy at WallachBeth
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use